Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy

Efavirenz (also known as DMP 266 or SUSTIVA) is a potent nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity and of HIV-1 replication in vitro and in vivo. Most patients on efavirenz-containing regimens have sustained antiviral responses; howeve...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Bacheler, Lee, Jeffrey, Susan, Hanna, George, D'Aquila, Richard, Wallace, Lany, Logue, Kelly, Cordova, Beverly, Hertogs, Kurt, Larder, Brendan, Buckery, Renay, Baker, David, Gallagher, Karen, Scarnati, Helen, Tritch, Radonna, Rizzo, Chris
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC114903/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11333879/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.11.4999-5008.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!